Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor × linifanib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumors 5 Carcinoma, Non-Small-Cell Lung 3 Solid Tumors 2 Solid Tumor 1 Neoplasms, Glandular and Epithelial 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasms 1 Neoplasm Metastasis 1 Liver Neoplasms 1 Liver Diseases 1 Digestive System Neoplasms 1 Digestive System Diseases 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Breast Neoplasms 1 Advanced or Metastatic Solid Tumors 1 Adenocarcinoma 1

Interventions

pembrolizumab 11 Injections 11 Paclitaxel 10 Docetaxel 9 Cisplatin 8 Capecitabine 8 Nivolumab 7 Fluorodeoxyglucose F18 7 Bevacizumab 7 toripalimab 6 senaparib 6 atezolizumab 6 Irinotecan 6 Fluorouracil 6 tislelizumab 5 Cyclophosphamide 5 apatinib 4 Leucovorin 4 Ipilimumab 4 Gemcitabine 4 spartalizumab 3 pertuzumab 3 olaparib 3 fludarabine 3 camrelizumab 3 Rifampin 3 Radiosurgery 3 Oxaliplatin 3 Midazolam 3 Itraconazole 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00718380 2017-11-21

A Phase 1 Study of ABT-869 in Subjects With Solid Tumors

AbbVie

Phase 1 Completed

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡